Facebook Linkedin RSS Twitter Youtube
Home 2023

Oxford Nanopore

Thanks DC: <i>GEN</i> Editors’ Final Report from ASHGGEN Editors’ Final Report from ASHG />
Industry News

Thanks DC: GEN Editors’ Final Report from ASHG

NGS Sample Prep: Enduring Basics and Evolving Enzyme Kits
Insights

NGS Sample Prep: Enduring Basics and Evolving Enzyme Kits

At ASHG, Fabric Genomics Announces Software Deals with Oxford Nanopore, DNAnexus
Artificial Intelligence

At ASHG, Fabric Genomics Announces Software Deals with Oxford Nanopore, DNAnexus

The NGS Race Is On: Souped-Up Sequencers Vie for Frontrunner Status
Insights

The NGS Race Is On: Souped-Up Sequencers Vie for Frontrunner Status

Ultima Genomics Bursts Onto NGS Scene Targeting the “$100 Genome”
Insights

Ultima Genomics Bursts Onto NGS Scene Targeting the “$100 Genome”

First Complete Human Genome, For Real This Time
News

First Complete Human Genome, For Real This Time

Next-Generation Sequencing Boosts Clinical Metagenomics
Infectious Diseases

Next-Generation Sequencing Boosts Clinical Metagenomics

X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results
GEN Edge

X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results

Oxford Nanopore Files for London IPO, with Potential Value of $5.5B
Coronavirus

Oxford Nanopore Files for London IPO, with Potential Value of $5.5B

Introducing “Close to the Edge”: A Zoom Conversation with PacBio CEO Christian Henry
Close to the Edge

Introducing “Close to the Edge”: A Zoom Conversation with PacBio CEO Christian Henry

12Page 1 of 2
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.